The cash flow of LABCORP HOLDINGS INC. over the past 10 years
Chart LABCORP HOLDINGS INC.: operating cash flow, capital expenditures, free cash flow, fiscal 2016–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, LABCORP HOLDINGS INC.'s operating cash flow was $1.64B and its capital expenditures $434.5M, leaving free cash flow of $1.21B. Free cash flow was above zero in all 10 years shown. It ranged from $874.1M in fiscal 2023 to $2.69B in fiscal 2021. Capital expenditures were highest in fiscal 2024, at $489.9M.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $1.64B | $434.5M | $1.21B |
| 2024ended Dec 31, 2024 | $1.59B | $489.9M | $1.1B |
| 2023ended Dec 31, 2023 | $1.33B | $453.6M | $874.1M |
| 2022ended Dec 31, 2022 | $1.96B | $429.3M | $1.53B |
| 2021ended Dec 31, 2021 | $3.11B | $421.5M | $2.69B |
| 2020ended Dec 31, 2020 | $2.14B | $381.7M | $1.75B |
| 2019ended Dec 31, 2019 | $1.44B | $400.2M | $1.04B |
| 2018ended Dec 31, 2018 | $1.31B | $379.8M | $925.6M |
| 2017ended Dec 31, 2017 | $1.5B | $312.9M | $1.19B |
| 2016ended Dec 31, 2016 | $1.2B | $278.9M | $918.2M |
Fiscal years as LABCORP HOLDINGS INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on LABCORP HOLDINGS INC.
- The revenue of LABCORP HOLDINGS INC.
- The profitability of LABCORP HOLDINGS INC.
- The debt of LABCORP HOLDINGS INC.
- The dividends of LABCORP HOLDINGS INC.
- All of LABCORP HOLDINGS INC.'s financials, charted
Companies of a similar size
- DGXQuest Diagnostics Inc
- UTHRUnited Therapeutics Corporation
- CNPCENTERPOINT ENERGY INC
- ULTAULTA BEAUTY, INC.
- CPAYCorpay, Inc
Not investment advice. This page shows what LABCORP HOLDINGS INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.